(CercleFinance.com) – Last Thursday, Affluent Medical announced the launch of a capital increase of 13 million euros, news that caused its share price to fall by more than 6% on Friday.
The title of the French medtech finds some color this Monday, rebounding 3.3%.
In a reaction note published early in the morning, analysts at Invest Securities recommend that investors subscribe to the offer, while lowering their target price to 4.1 euros, against 9.2 euros previously.
For the brokerage firm, the operation will allow the company to extend its financial visibility for eight to 11 months and to more comfortably anticipate a ‘newsflow’ deemed attractive over the coming months.
This capital increase should thus make it possible, according to Invest Securities, ‘to find valuation levels more in line with the pipeline and to approach future financing maturities more serenely’.